The The Effect of Vitamin E Therapy on Post Chemotherapy Mucositis in Leukemic Patients
Abstract
Introduction: Chemotherapy is one of the most common treatment modalities for blood malignancies such as leukemia, with several potential complications. Mucositis is one of the complications of chemotherapy, manifested with different severities. The aim of this study was to evaluate the prophylactic effect of vitamin E on reducing the severity of chemotherapy-induced mucositis.
Materials & Methods: This randomized clinical trial was performed in Ahvaz’s Shafa Hospital on 56 leukemic patients, undergoing chemotherapy. The patients were divided into 3 groups: 1) systemic treatment group, case group 1; 2) topical treatment group, the case group 2; and 3) control group. The oral mucosa of the patients was evaluated for the severity of mucositis and the patient’s response to pain. Data were analyzed with Mann-Whitney test and t-test (α = 0.05).
Results: In relation to the severity of mucositis, based on the results of Mann-Whitney test, there was a significant difference between the case group 2 and control group (p value ≤ 0.01). There was no significant difference between the two case groups (p value = 0.2). In relation to the patient’s response to pain, there was a significant difference between the case group 2 and control group (p value ≤ 0.01). There was no significant difference between the two case groups (p value = 0.4). Therefore, vitamin E decreased the incidence of thermotherapy-induced mucositis.
Conclusion: Within the limitations of this study, vitamin E in its topical form is an effective medicament for reducing the severity and pain of chemotherapy-induced mucositis.
Key words: Chemotherapy, Oral mucositis, Vitamin E.
References
2. Aster J. Kumar V. White cells and lymph nodes. In: Cotran RS. editor. Robbins pathologic basis of disease. Philadelphia, PA: Saunders; 1999. p. 657-8.
3. Pourshahidi S, Giti R, Karimi M, Ebrahimi H. The prevalence of oral manifestations in children with hematologic malignancys. Elixir Human Physio 2012; 49(8): 9718-20.
4. Terezhalmy GT, Whitmyer CC, Markman M. Cancer chemotherapeutic agents. Dent Clin North Am 1996; 40(3): 709-26.
5. Groenwald SL, Frogge M, Goodman M, Yarbro CH. Clinical guide to cancer nursing. Burlington, Massachusetts: Jones & Bartlett Learning, LLC; 1997.
6. McCarthy GM, Skillings JR. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer. Oral Surg Oral Med Oral Pathol 1992; 74(3): 299-304.
7. Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ. Patient reports of complications of bone marrow transplantation. Support Care Cancer 2000; 8(1): 33-9.
8. Sonis ST, Oster G, Fuchs H, Bellm L, Bradford WZ, Edelsberg J, et al. Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 2001; 19(8): 2201-5.
9. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100(9 Suppl): 2026-46.
10. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004; 4(4): 277-84.
11. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001; 51(5): 290-315.
12. Arbabi-Kalati F, Arbabi-Kalati F, Deghatipour M, Moghaddam A. Evaluation of the efficacy of zinc sulfate in the prevention of chemotherapy-induced mucositis: a double-blind randomized clinical trial. Arch Iran Med 2012; 15(7): 413-7.
13. Mehdipour M, Zenoz AT, Kermani IA, Hosseinpour A. A comparison between zinc sulfate and chlorhexidine gluconate mouthwashes in the prevention of chemotherapy-induced oral mucositis. Daru 2011; 19(1): 71-3.
14. Burket LW, Greenberg MS, Glick M, Ship JA. Burket's oral medicine. Washington DC: PMPH-USA; 2008.
15. El-Housseiny AA, Saleh SM, El-Masry AA, Allam AA. The effectiveness of vitamin" E" in the treatment of oral mucositis in children receiving chemotherapy. J Clin Pediatr Dent 2007; 31(3): 167-70.
16. Lopez I, Goudou C, Ribrag V, Sauvage C, Hazebroucq G, Dreyfus F. [Treatment of mucositis with vitamin E during administration of neutropenic antineoplastic agents]. Ann Med Interne (Paris) 1994; 145(6): 405-8. [In French].
17. Üçüncü H, Ertekin MV, Yörük Ö, Sezen O, Özkan A, Erdoğan F, et al. Vitamin E and L-carnitine, separately or in combination, in the prevention of radiation-induced oral mucositis and myelosuppression: a controlled study in a rat model. J Radiat Res 2006; 47(1): 91-102.
18. Khurana H, Pandey RK, Saksena AK, Kumar A. An evaluation of Vitamin E and Pycnogenol in children suffering from oral mucositis during cancer chemotherapy. Oral Dis 2013; 19(5): 456-64.
19. Sung L, Tomlinson GA, Greenberg ML, Koren G, Judd P, Ota S, et al. Serial controlled N-of-1 trials of topical vitamin E as prophylaxis for chemotherapy-induced oral mucositis in paediatric patients. Eur J Cancer 2007; 43(8): 1269-75.
20. Ertekin MV, Koç M, Karslioglu I, Sezen O. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study. Int J Radiat Oncol Biol Phys 2004; 58(1): 167-74.
21. Wadleigh RG, Redman RS, Graham ML, Krasnow SH, Anderson A, Cohen MH. Vitamin E in the treatment of chemotherapy-induced mucositis. Am J Med 1992; 92(5): 481-4.
22. Shahrasbi H. Food sources and lively effect of vitamins. Tehran, Iran: Jahad Daneshgahi Publications 2011. p. 114-5. [In Persian].
23. Keller KL, Fenske NA. Uses of vitamins A, C, and E and related compounds in dermatology: a review. J Am Acad Dermatol 1998; 39(4 Pt 1): 611-25.
Based on the obtained author agreement upon submission, “Journal of Isfahan Dental School” is the copyright owner of the published material. However, this is an open access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author.
Article evaluation process:
- The article assessment will be started after being submitted on the journal site and will be sent to the reviewers for scientific evaluation after receiving the submission fee and if the structural principles are observed. The results of the judging will be reviewed by the Writers' Council and, if necessary, amendments will be sent to the responsible author. After final correction and approval, the articles are published in the journal in the order of the article approval date.
- Clinical trial articles must be previously registered on the site (www.IRCT.ir) and their registration number must be mentioned at the beginning of the Materials and Methods.
- Case report articles must have a consent letter and a code of ethics.
- The journal has the right to accept or reject the article and also reserves the right to scientific and literary editing and, if necessary, summarizing the article. After submitting the article, all rights to it belong to the magazine.
- The journal will not be liable for litigation between authors as well as the correctness of the academic rank or affiliation of the authors. Also, the accuracy of the contents of the article is the responsibility of all the author (s).
- After the article enters the final stage (References check), it is not possible for the author (s) to cancel the publication of the article.
- After the Proof version is approved by the responsible author, it is not possible to change the number or order of the authors of the article.
Address: Journal of Isfahan Dental School, School of Dentistry, Isfahan University of Medical Sciences, Hezar Jerib St. Isfahan, IRAN.
Postal Code: 81746-72461
Phone: 031-37925523
Fax: 031-36687080
Email: jids@dnt.mui.ac.ir
URL: http://jids.journalonweb.ir/index.php/jids
